Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up study of childhood dental caries prevention strategies
ACTRN12610000325000Phase 4Active, not recruiting
- Sponsor
- Metro South Health
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluoride toothpaste, chlorhexidine and casein phosphopeptide-amorphous calcium phosphate in carious lesion (3 arms), sponsored by Metro South Health. Primary endpoints: Number of carious lesions or demineralized tooth surfaces and Number of teeth with erosion. Started Jan 2011; status: active, not recruiting.
02
Drugs
fluoride toothpastechlorhexidinecasein phosphopeptide-amorphous calcium phosphate
03
Conditions
carious lesion
Beyond the preview
Go deeper on ACTRN12610000325000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000325000.